London Blood Pressure & PoTS Clinic

Professor Melvin Lobo stands as a prominent figure in the realm of cardiovascular medicine, specializing in the intricate field of hypertension. Renowned as the Director of Bart’s Blood Pressure Clinic, Professor Lobo has earned international recognition as a Hypertension Centre of Excellence accredited by the esteemed European Society of Hypertension. His clinic is a beacon for complex hypertensive cases, drawing referrals nationally and globally due to its exceptional expertise.

Aligned with the prestigious William Harvey Research Institute, Professor Lobo’s clinic has played a pivotal role in groundbreaking studies within the hypertension domain. These include pivotal contributions to landmark studies such as the ASCOT study, which fundamentally impacted UK Hypertension guidelines. Additionally, the clinic's participation in the Symplicity HTN-2 study exploring renal denervation for treatment-resistant hypertension has been revolutionary. Notably, Professor Lobo led the recent ROX Control Hypertension Study, focusing on a novel central iliac arteriovenous anastomosis to address uncontrolled hypertension.

Since October 2011, Professor Lobo has been instrumental in co-hosting and chairing the annual UK Symposia on Renal Denervation at the Royal College of Physicians. Collaborating with a panel of distinguished international authorities in hypertension medicine and interventionists, these symposia have contributed significantly to advancing knowledge and practices in the field.

A key contributor in shaping renal denervation strategies, Professor Lobo serves on the Joint British Societies steering committee on renal denervation. His authored JBS Consensus Statements on Renal Denervation have provided pivotal guidance in this evolving domain. Widely recognized for his expertise, Professor Lobo has delivered extensive lectures and published prolifically on hypertension and innovative therapies for resistant hypertension, enriching the medical community with his wealth of knowledge and insights.

Professor Melvin Lobo's unwavering commitment to advancing hypertension research, coupled with his pivotal role in transforming clinical guidelines and innovative therapies, positions him as a leading authority in cardiovascular medicine, shaping the landscape of hypertension management and treatment worldwide.

• Consultant Cardiovascular Physician and Clinical Hypertension Specialist, Barts Health Trust
• Hon Senior Lecturer, NIHR Barts CV BRU, William Harvey Research Institute, Queen Mary University London
• Positions of responsibility:
• Director Barts Blood Pressure Clinic
• Chief Investigator EnligHTN II study
• Chief Investigator ROX Coupler Study and ROX Global Registry
• Principal Investigator Symplicity HTN-2 Study
• Special Adviser to NICE: Renal Denervation/Baroreflex Activation
• ESH Working Group on Interventional treatment of Hypertension
• Steering Group UK National Registry for renal denervation
• Chair of the Bart’s Health Trust Joint Prescribing Group

• University of Manchester Medical School
• 1989 Bachelor of Medicine and Bachelor of Surgery MB ChB.
• 2015 Fellow of the British Hypertension Society
• 2010 Fellow of the Royal College of Physicians (FRCP London)
• 2000 PhD Thesis (Vascular Biology), University of London

• Fellow of the Royal College of Physicians, London
• Fellow of the British Hypertension Society and member of the European Society of Hypertension
• Member of the British Pharmacological Society
• Advisory boards: Medtronic, St Jude Medical, Cardiosonic, ROX Medical
• Board Member: GiveBackBox® (Los Angeles, California, USA)